Qiangnu Zhang

535 total citations
24 papers, 372 citations indexed

About

Qiangnu Zhang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qiangnu Zhang has authored 24 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qiangnu Zhang's work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and Ferroptosis and cancer prognosis (4 papers). Qiangnu Zhang is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and Ferroptosis and cancer prognosis (4 papers). Qiangnu Zhang collaborates with scholars based in China, Germany and Netherlands. Qiangnu Zhang's co-authors include Liping Liu, Quan Liu, Juan Liao, Wenjian Zhang, Xiaotao Huang, Stéphanie Roessler, Lijun Qiao, Liping Liu, Lulin Shi and Weibin Hu and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Qiangnu Zhang

23 papers receiving 370 citations

Peers

Qiangnu Zhang
Qinliang Fang China
Jingsheng Yuan China
Liutao Chen China
Yajuan Cao China
Yemei Song China
Chunbo Zhuang China
Yihang Guo China
Jiwei Xu China
Meng‐Han Wu Taiwan
Qinliang Fang China
Qiangnu Zhang
Citations per year, relative to Qiangnu Zhang Qiangnu Zhang (= 1×) peers Qinliang Fang

Countries citing papers authored by Qiangnu Zhang

Since Specialization
Citations

This map shows the geographic impact of Qiangnu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiangnu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiangnu Zhang more than expected).

Fields of papers citing papers by Qiangnu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiangnu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiangnu Zhang. The network helps show where Qiangnu Zhang may publish in the future.

Co-authorship network of co-authors of Qiangnu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiangnu Zhang. A scholar is included among the top collaborators of Qiangnu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiangnu Zhang. Qiangnu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Qiangnu, Chu‐Li Fu, Zuotian Huang, et al.. (2024). CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis. Cancer Research. 85(3). 515–534. 4 indexed citations
3.
Zhang, Qiangnu & Liping Liu. (2024). Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough. Cancer Letters. 587. 216691–216691. 7 indexed citations
4.
Li, Yingxi, Ying Wang, Qing Li, et al.. (2024). An all-in-one “multifunctional hydrogel”: Through antibacterial, anti-inflammatory, and angiogenic to promoting MRSA-infected bone defect repair. Chemical Engineering Journal. 503. 158132–158132. 5 indexed citations
5.
Fu, Chu‐Li, Zhengwei Zhao, & Qiangnu Zhang. (2024). The crosstalk between cellular survival pressures and N6-methyladenosine modification in hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 24(1). 67–75. 1 indexed citations
6.
Zhang, Qiangnu, Teng Wei, Wen Jin, et al.. (2023). Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism. Journal of Hepatology. 80(2). 293–308. 29 indexed citations
7.
Zhang, Qiangnu, Teng Wei, Siqi Zhu, et al.. (2023). Hypoxia-Responsive lncRNA AC115619 Encodes a Micropeptide That Suppresses m6A Modifications and Hepatocellular Carcinoma Progression. Cancer Research. 83(15). 2496–2512. 43 indexed citations
8.
Zhang, Qiangnu, Weibin Hu, Quan Liu, et al.. (2023). IHGA: An interactive web server for large-scale and comprehensive discovery of genes of interest in hepatocellular carcinoma. Computational and Structural Biotechnology Journal. 21. 3987–3998. 1 indexed citations
9.
Zhang, Qiangnu, Wei Teng, Quan Liu, et al.. (2023). Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma. Oncogene. 42(19). 1509–1523. 62 indexed citations
10.
Li, Kunsheng, et al.. (2022). ox-LDL regulates proliferation and apoptosis in VSMCs by controlling the miR-183-5p/FOXO1. Genes & Genomics. 44(6). 671–681. 9 indexed citations
11.
Li, Kunsheng, et al.. (2022). LncRNA KCNQ1OT1 Participates in Ox-LDL-Induced Proliferation/Apoptosis Imbalance in Vascular Smooth Muscle Cells by Regulating the MiR-196a-5p/FOXO1 Axis. Journal of Stroke and Cerebrovascular Diseases. 31(8). 106622–106622. 3 indexed citations
12.
Hong, Jun, Shi‐Jing Mo, Ziqiang Shao, et al.. (2021). lncRNA‐SNHG14 Plays a Role in Acute Lung Injury Induced by Lipopolysaccharide through Regulating Autophagy via miR‐223‐3p/Foxo3a. Mediators of Inflammation. 2021(1). 7890288–7890288. 29 indexed citations
13.
14.
Qiao, Lijun, Qiangnu Zhang, Zhe Sun, et al.. (2021). The E2F1/USP11 positive feedback loop promotes hepatocellular carcinoma metastasis and inhibits autophagy by activating ERK/mTOR pathway. Cancer Letters. 514. 63–78. 36 indexed citations
15.
Sun, Wenwen, et al.. (2021). lncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability. Biochemical and Biophysical Research Communications. 566. 101–107. 15 indexed citations
16.
Zhang, Qiangnu, Lijun Qiao, Quan Liu, et al.. (2021). Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma. Aging. 13(5). 6525–6553. 13 indexed citations
17.
Zhang, Qiangnu, et al.. (2020). Hypoxia-Induced lncRNA-NEAT1 Sustains the Growth of Hepatocellular Carcinoma via Regulation of miR-199a-3p/UCK2. Frontiers in Oncology. 10. 998–998. 32 indexed citations
18.
19.
Goeppert, Benjamin, Marcus Renner, Stephan Singer, et al.. (2019). Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma. Scientific Reports. 9(1). 4338–4338. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qinliang Fang Breakdown of academic impact, for papers by Jingsheng Yuan Breakdown of academic impact, for papers by Liutao Chen Breakdown of academic impact, for papers by Yajuan Cao Breakdown of academic impact, for papers by Yemei Song Breakdown of academic impact, for papers by Chunbo Zhuang Breakdown of academic impact, for papers by Yihang Guo Breakdown of academic impact, for papers by Jiwei Xu Breakdown of academic impact, for papers by Meng‐Han Wu
Rankless by CCL
2026